Table 2.
Clinical outcomes of the patients with autosomal dominant polycystic kidney disease.
| Variables | All patients (n = 288) |
|---|---|
| Cyst complication (%) | 43 (14.9) |
| Cyst infection | 28 (65.1) |
| Cyst hemorrhage | 15 (34.9) |
| ESRD (%) | 132 (45.8) |
| RRT (%) | 104 (36.1) |
| Hemodialysis | 74 (71.1) |
| Peritoneal dialysis | 2 (1.9) |
| Kidney transplantation | 28 (26.9) |
| Duration from diagnosis to RRT (months) | 110.8 ± 93.9 |
| Follow-up duration (months) | 117.1 ± 102.1 |
| Mortality (%) | 28 (9.7) |
| Causes of mortality (%) | |
| Infection | 12 (42.9) |
| Cyst infection | 3 (10.7) |
| Urinary tract infection | 2 (7.1) |
| Pneumonia | 2 (7.1) |
| Catheter-related infection | 2 (7.1) |
| Bacterial meningitis | 1 (3.6) |
| Pseudomembranous colitis | 1 (3.6) |
| Colitis | 1 (3.6) |
| Cerebral hemorrhage | 1 (3.6) |
| Sudden cardiac death | 7 (25.0) |
| Pulmonary thromboembolism | 2 (7.1) |
| Others | 6 (21.4) |
Values are expressed as mean ± SD, n (%).
ESRD = end-stage renal disease, RRT = renal replacement therapy.